LCMS webinars focusing on LC/TOF - page 2

Advancing Proteomics with ZenoTOF: From Single-Cell Analysis to Plasma Biomarker Discovery

Advancing Proteomics with ZenoTOF: From Single-Cell Analysis to Plasma Biomarker Discovery

Discover how ZenoTOF high-resolution mass spectrometry is accelerating single-cell proteomics and plasma biomarker discovery through enhanced sensitivity, throughput, and automation.
RECORD
|
Already taken place Tu, 30.6.2026
Tu, 30.6.2026
SCIEX
tag
share
more
Advancing Proteomics with ZenoTOF: From Single-Cell Analysis to Plasma Biomarker Discovery
Lower the Flow to see even more

Lower the Flow to see even more

Boost large molecule sensitivity in bioanalysis. Learn how switching to microflow LC-MS/MS improves limits of quantification, cuts costs, and reduces solvent usage.
RECORD
|
Already taken place Th, 25.6.2026
Th, 25.6.2026
Waters Corporation
tag
share
more
Lower the Flow to see even more
Clear the Noise: Improving Resolution of GLP-1 Receptor Agonist and Insulin Impurities

Clear the Noise: Improving Resolution of GLP-1 Receptor Agonist and Insulin Impurities

Learn how to gain greater resolution for your GLP-1 RA and insulin impurity analysis separations.
RECORD
|
Already taken place We, 24.6.2026
We, 24.6.2026
Waters Corporation
tag
share
more
Clear the Noise: Improving Resolution of GLP-1 Receptor Agonist and Insulin Impurities
Development and Implementation of an Efficient LC-TOF MS Screening Workflow in Seized Drug Analysis

Development and Implementation of an Efficient LC-TOF MS Screening Workflow in Seized Drug Analysis

The upcoming webinar will address how the Acquity UPLC with the RDa detector has been employed to develop a workflow for screening seized drug cases.
RECORD
|
Already taken place We, 17.6.2026
We, 17.6.2026
Waters Corporation
tag
share
more
Development and Implementation of an Efficient LC-TOF MS Screening Workflow in Seized Drug Analysis
Innovations and Emerging Tools in Peptide Science

Innovations and Emerging Tools in Peptide Science

Master peptide characterization and manufacturing. Discover Agilent solutions for GLP-1 API scale-up, xCELLigence cell-based bioassays, non-destructive Raman RMID, and inert LC/MS impurity profiling workflows.
RECORD
|
Already taken place Tu, 16.6.2026
Tu, 16.6.2026
Agilent Technologies
tag
share
more
Innovations and Emerging Tools in Peptide Science
Seeing More with Greater Confidence: Next-Generation HRMS for Toxicology Screening

Seeing More with Greater Confidence: Next-Generation HRMS for Toxicology Screening

In this webinar, we will introduce the Xevo™ MRT HRMS platform as a powerful solution for broad, high‑confidence toxicology screening.
RECORD
|
Already taken place Th, 11.6.2026
Th, 11.6.2026
Waters Corporation
tag
share
more
Seeing More with Greater Confidence: Next-Generation HRMS for Toxicology Screening
Pharma fundamentals: To Be or Not to Be? QQQ vs HRMS Quant

Pharma fundamentals: To Be or Not to Be? QQQ vs HRMS Quant

Join this Pharma Fundamentals masterclass to compare sensitivity, selectivity, and workflow efficiency using SCIEX 7500+ and ZenoTOF 7600 systems.
RECORD
|
Already taken place Th, 11.6.2026
Th, 11.6.2026
SCIEX
tag
share
more
Pharma fundamentals: To Be or Not to Be? QQQ vs HRMS Quant
HRMS workflows for peptide impurity characterization

HRMS workflows for peptide impurity characterization

Explore advanced HRMS and CMC strategies for peptide impurity characterization, including LC-HRMS workflows, EAD fragmentation, and regulatory considerations for GLP-1 RAs and oligonucleotides.
RECORD
|
Already taken place We, 20.5.2026
We, 20.5.2026
SCIEX
tag
share
more
HRMS workflows for peptide impurity characterization
The proteomic LC-MS strategy revealing autoimmune mechanisms with new clarity for clinical research

The proteomic LC-MS strategy revealing autoimmune mechanisms with new clarity for clinical research

Integrated proteomics and multiomics strategies are transforming the way researchers investigate immune dysregulation and disease mechanisms.
RECORD
|
Already taken place Tu, 19.5.2026
Tu, 19.5.2026
SelectScience
tag
share
more
The proteomic LC-MS strategy revealing autoimmune mechanisms with new clarity for clinical research
Accelerating LC/MS Impurity Screening Followed by ECD-Based Sequence Analysis for GLP-1 Analogs

Accelerating LC/MS Impurity Screening Followed by ECD-Based Sequence Analysis for GLP-1 Analogs

Episode 4 of Peptide 360 presents a staged LC/MS workflow for rapid GLP-1 impurity screening followed by ECD-based sequence analysis for precise structural confirmation and faster decisions.
RECORD
|
Already taken place Fr, 8.5.2026
Fr, 8.5.2026
Agilent Technologies
tag
share
more
Accelerating LC/MS Impurity Screening Followed by ECD-Based Sequence Analysis for GLP-1 Analogs
 

Related content

Webinars LabRulezLCMS Week 34/2026

Webinars LabRulezLCMS Week 34/2026

Mo, 17.8.2026
LabRulez
An Analyte-Specific LC-IMS-HRMS Framework for Enhanced Identification Confidence in Target Screening of Contaminants in Complex Matrices

An Analyte-Specific LC-IMS-HRMS Framework for Enhanced Identification Confidence in Target Screening of Contaminants in Complex Matrices

Mo, 17.8.2026
LabRulez
LC-MS Metabolomics and Next-Generation Ionization Technologies

LC-MS Metabolomics and Next-Generation Ionization Technologies

Fr, 14.8.2026
Organomation
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike